- Home
- LGCY vs OMGA Comparison
LGCY vs OMGA Comparison
Compare LGCY & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCY
- OMGA
- Stock Information
- Founded
- LGCY 2009
- OMGA 2017
- Country
- LGCY United States
- OMGA United States
- Employees
- LGCY N/A
- OMGA N/A
- Industry
- LGCY
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- LGCY
- OMGA Health Care
- Exchange
- LGCY NYSE
- OMGA Nasdaq
- Market Cap
- LGCY 101.9M
- OMGA 53.6M
- IPO Year
- LGCY 2024
- OMGA 2021
- Fundamental
- Price
- LGCY $8.25
- OMGA $0.81
- Analyst Decision
- LGCY Strong Buy
- OMGA Strong Buy
- Analyst Count
- LGCY 2
- OMGA 5
- Target Price
- LGCY $9.35
- OMGA $9.20
- AVG Volume (30 Days)
- LGCY 113.8K
- OMGA 237.3K
- Earning Date
- LGCY 11-14-2024
- OMGA 11-14-2024
- Dividend Yield
- LGCY N/A
- OMGA N/A
- EPS Growth
- LGCY 90.87
- OMGA N/A
- EPS
- LGCY 0.63
- OMGA N/A
- Revenue
- LGCY $49,638,473.00
- OMGA $8,095,000.00
- Revenue This Year
- LGCY N/A
- OMGA $183.26
- Revenue Next Year
- LGCY N/A
- OMGA N/A
- P/E Ratio
- LGCY $13.19
- OMGA N/A
- Revenue Growth
- LGCY 32.36
- OMGA 185.04
- 52 Week Low
- LGCY $3.60
- OMGA $0.74
- 52 Week High
- LGCY $10.37
- OMGA $6.30
- Technical
- Relative Strength Index (RSI)
- LGCY N/A
- OMGA 39.66
- Support Level
- LGCY N/A
- OMGA $0.74
- Resistance Level
- LGCY N/A
- OMGA $0.84
- Average True Range (ATR)
- LGCY 0.00
- OMGA 0.07
- MACD
- LGCY 0.00
- OMGA -0.01
- Stochastic Oscillator
- LGCY 0.00
- OMGA 14.89
About LGCY LEGACY EDUCATION INC
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.